Page last updated: 2024-10-27

fenofibrate and Hypolipoproteinemia

fenofibrate has been researched along with Hypolipoproteinemia in 3 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Research Excerpts

ExcerptRelevanceReference
"The purpose of this study was to investigate the effect of low high-density-lipoprotein (HDL) combined with hypertriglyceridemia in coronary artery disease (CAD) patients on prostaglandin I2 (PGI2) biological activity in relation to lipid regulating treatment."1.30Effect of low HDL combined with hypertriglyceridemia in coronary artery disease patients on PGI2 biological activity in relation to lipid regulating treatment. ( Dai, G; Feng, Z; Li, J; Wang, C; Wei, W; Yang, Y; Zhou, B, 1998)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murphy, MJ2
Duncan, A1
Vallance, BD1
Packard, CJ2
O'Reilly, DS2
Li, J1
Dai, G1
Feng, Z1
Wang, C1
Yang, Y1
Wei, W1
Zhou, B1

Other Studies

3 other studies available for fenofibrate and Hypolipoproteinemia

ArticleYear
Iatrogenic profound hypoalphalipoproteinaemia: an unrecognised cause of very low HDL cholesterol.
    Postgraduate medical journal, 1995, Volume: 71, Issue:838

    Topics: Adult; Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Drug Interactions; Female; Fenofibra

1995
Fibrates and HDL cholesterol.
    Annals of clinical biochemistry, 1997, Volume: 34 ( Pt 1)

    Topics: Apolipoprotein A-I; Cholesterol, HDL; Clofibric Acid; Dose-Response Relationship, Drug; Female; Feno

1997
Effect of low HDL combined with hypertriglyceridemia in coronary artery disease patients on PGI2 biological activity in relation to lipid regulating treatment.
    Journal of Tongji Medical University = Tong ji yi ke da xue xue bao, 1998, Volume: 18, Issue:2

    Topics: Coronary Disease; Epoprostenol; Fenofibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Hyp

1998